Prime Stock Recommendation: An MNC Pharma staple for predictable growth & regular income

PrimeInvestor is now a SEBI-registered Portfolio Management Service (minimum investment ₹50 lakh). We no longer offer research subscriptions, stock or fund recommendations, or DIY advisory. This article is from our research archive (2020–2026) and is for information only. Explore PrimeInvestor PMS →